John F. Carey - 20 Jul 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP of Operations
Signature: By: /s/ Stephen Gordon, as attorney-in-fact
Issuer symbol: TMDX
Transactions as of: 20 Jul 2022
Net transactions value: -$30,862
Form type: 4
Filing time: 22 Jul 2022, 17:00:21 UTC
Previous filing: 12 Jul 2022
Next filing: 01 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$6,052	+375	+99%	$16.14^*	754	20 Jul 2022	Direct	F1
transaction	TMDX	Common Stock	Options Exercise	$14,940	+1,125	+149%	$13.28^*	1,879	20 Jul 2022	Direct	F1
transaction	TMDX	Common Stock	Sale	$51,855	-1,500	-80%	$34.57	379	20 Jul 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-375	-5.7%	$0.000000	6,250	20 Jul 2022	Common Stock	375	$16.14	Direct	F1, F3
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-1,125	-3%	$0.000000	36,875	20 Jul 2022	Common Stock	1,125	$13.28	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.50 to $34.71, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares.
F4	The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares.